Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nuclear import signal receptor activity	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.52e-06	20	206	5	GO:0061608
GeneOntologyMolecularFunction	nuclear localization sequence binding	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	7.47e-06	27	206	5	GO:0008139
GeneOntologyMolecularFunction	nucleocytoplasmic carrier activity	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.79e-05	32	206	5	GO:0140142
GeneOntologyMolecularFunction	signal sequence binding	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.78e-04	51	206	5	GO:0005048
GeneOntologyBiologicalProcess	NLS-bearing protein import into nucleus	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.46e-06	20	211	5	GO:0006607
GeneOntologyCellularComponent	NLS-dependent protein nuclear import complex	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	2.42e-08	10	211	5	GO:0042564
GeneOntologyCellularComponent	nucleocytoplasmic transport complex	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	7.47e-08	12	211	5	GO:0031074
GeneOntologyCellularComponent	pi-body	AGO2 DDX4 ASZ1	1.58e-04	11	211	3	GO:0071546
GeneOntologyCellularComponent	germ plasm	AGO2 DDX4 ASZ1 HELZ2	1.97e-04	29	211	4	GO:0060293
GeneOntologyCellularComponent	pole plasm	AGO2 DDX4 ASZ1 HELZ2	1.97e-04	29	211	4	GO:0045495
GeneOntologyCellularComponent	P granule	AGO2 DDX4 ASZ1 HELZ2	1.97e-04	29	211	4	GO:0043186
GeneOntologyCellularComponent	striated muscle myosin thick filament	MYOM1 OBSCN	6.00e-04	4	211	2	GO:0005863
Domain	IG	MYOM1 OBSCN NCAM1 IL1RL2 NCR3LG1 TYRO3 FCGR2A PVR NECTIN2 NCR2 NCR1 LILRA5 ADGRA3 HSPG2 ICOSLG KALRN TMIGD2 NTRK2 ICAM1 ADAMTSL3 ADGRA2 CD160 HMCN1	2.66e-10	421	205	23	SM00409
Domain	Ig_sub	MYOM1 OBSCN NCAM1 IL1RL2 NCR3LG1 TYRO3 FCGR2A PVR NECTIN2 NCR2 NCR1 LILRA5 ADGRA3 HSPG2 ICOSLG KALRN TMIGD2 NTRK2 ICAM1 ADAMTSL3 ADGRA2 CD160 HMCN1	2.66e-10	421	205	23	IPR003599
Domain	Ig-like_fold	MYOM1 OBSCN NCAM1 IL1RL2 NCR3LG1 TYRO3 FCGR2A CRLF3 PVR NECTIN2 PKHD1 NCR2 NCR1 LILRA5 ADGRA3 TRIM46 HSPG2 ICOSLG COL12A1 KALRN TMIGD2 NTRK2 ICAM1 ADAMTSL3 ADGRA2 CD160 HMCN1 IL6ST SORL1	9.19e-10	706	205	29	IPR013783
Domain	-	MYOM1 OBSCN NCAM1 IL1RL2 NCR3LG1 TYRO3 FCGR2A CRLF3 PVR NECTIN2 PKHD1 NCR2 NCR1 LILRA5 ADGRA3 TRIM46 HSPG2 COL12A1 KALRN TMIGD2 NTRK2 ICAM1 ADAMTSL3 ADGRA2 CD160 HMCN1 IL6ST SORL1	9.96e-10	663	205	28	2.60.40.10
Domain	Arm_3	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	3.13e-09	7	205	5	PF16186
Domain	Importing_su_alpha	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	3.13e-09	7	205	5	IPR024931
Domain	IBB	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	3.13e-09	7	205	5	PF01749
Domain	Arm_3	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	3.13e-09	7	205	5	IPR032413
Domain	Ig-like_dom	MYOM1 OBSCN NCAM1 IL1RL2 NCR3LG1 TYRO3 FCGR2A PVR NECTIN2 NCR2 NCR1 LILRA5 ADGRA3 HSPG2 ICOSLG KALRN TMIGD2 NTRK2 ICAM1 ADAMTSL3 ADGRA2 CD160 HMCN1	8.08e-09	503	205	23	IPR007110
Domain	IBB	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	8.27e-09	8	205	5	PS51214
Domain	Importin-a_IBB	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.84e-08	9	205	5	IPR002652
Domain	-	MON2 KPNA6 HSPBP1 CUL7 RRP12 KPNA1 KPNA3 KPNA4 KPNA5 NCAPD3 IPO7 COPB1 PPP2R1A PPP2R1B CTNNB1	2.44e-08	222	205	15	1.25.10.10
Domain	IG_LIKE	MYOM1 OBSCN NCAM1 IL1RL2 NCR3LG1 TYRO3 FCGR2A PVR NECTIN2 NCR2 NCR1 ADGRA3 HSPG2 ICOSLG KALRN TMIGD2 NTRK2 ICAM1 ADAMTSL3 ADGRA2 CD160 HMCN1	2.51e-08	491	205	22	PS50835
Domain	ig	MYOM1 OBSCN NCAM1 IL1RL2 TYRO3 FCGR2A PVR NECTIN2 ADGRA3 HSPG2 TMIGD2 ADAMTSL3 HMCN1	1.86e-07	190	205	13	PF00047
Domain	Immunoglobulin	MYOM1 OBSCN NCAM1 IL1RL2 TYRO3 FCGR2A PVR NECTIN2 ADGRA3 HSPG2 TMIGD2 ADAMTSL3 HMCN1	1.86e-07	190	205	13	IPR013151
Domain	ARM_REPEAT	KPNA6 HSPBP1 KPNA1 KPNA3 KPNA4 KPNA5 CTNNB1	2.38e-07	40	205	7	PS50176
Domain	ARM-like	MON2 KPNA6 HSPBP1 CUL7 RRP12 KPNA1 KPNA3 KPNA4 KPNA5 NCAPD3 IPO7 COPB1 PPP2R1A PPP2R1B CTNNB1	3.16e-07	270	205	15	IPR011989
Domain	Arm	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5 CTNNB1	9.52e-07	31	205	6	PF00514
Domain	ARM-type_fold	MON2 KPNA6 HSPBP1 CUL7 RRP12 KPNA1 KPNA3 KPNA4 KPNA5 NCAPD3 IPO7 COPB1 PPP2R1A PPP2R1B BZW1 CTNNB1	1.12e-06	339	205	16	IPR016024
Domain	ARM	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5 CTNNB1	4.57e-06	40	205	6	SM00185
Domain	Ig_I-set	MYOM1 OBSCN NCAM1 TYRO3 ADGRA3 HSPG2 KALRN TMIGD2 NTRK2 ADAMTSL3 HMCN1	8.36e-06	190	205	11	IPR013098
Domain	I-set	MYOM1 OBSCN NCAM1 TYRO3 ADGRA3 HSPG2 KALRN TMIGD2 NTRK2 ADAMTSL3 HMCN1	8.36e-06	190	205	11	PF07679
Domain	Armadillo	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5 CTNNB1	1.20e-05	47	205	6	IPR000225
Domain	FN3	MYOM1 OBSCN NCAM1 TYRO3 CRLF3 TRIM46 COL12A1 KALRN IL6ST SORL1	3.89e-05	185	205	10	SM00060
Domain	IGc2	MYOM1 OBSCN NCAM1 TYRO3 FCGR2A LILRA5 HSPG2 KALRN NTRK2 ADAMTSL3 HMCN1	5.98e-05	235	205	11	SM00408
Domain	Ig_sub2	MYOM1 OBSCN NCAM1 TYRO3 FCGR2A LILRA5 HSPG2 KALRN NTRK2 ADAMTSL3 HMCN1	5.98e-05	235	205	11	IPR003598
Domain	FN3	MYOM1 OBSCN NCAM1 TYRO3 CRLF3 TRIM46 COL12A1 KALRN IL6ST SORL1	7.20e-05	199	205	10	PS50853
Domain	fn3	MYOM1 OBSCN NCAM1 TYRO3 TRIM46 COL12A1 KALRN IL6ST SORL1	7.71e-05	162	205	9	PF00041
Domain	FN3_dom	MYOM1 OBSCN NCAM1 TYRO3 CRLF3 TRIM46 COL12A1 KALRN IL6ST SORL1	1.08e-04	209	205	10	IPR003961
Domain	PP2A_A_meta	PPP2R1A PPP2R1B	1.20e-04	2	205	2	IPR031090
Domain	REELIN	RELN FRRS1	3.57e-04	3	205	2	PS51019
Domain	DUF2075	SLFN13 SLFN11	3.57e-04	3	205	2	PF09848
Domain	Reeler_dom	RELN FRRS1	3.57e-04	3	205	2	IPR002861
Domain	Reeler	RELN FRRS1	3.57e-04	3	205	2	PF02014
Domain	DUF2075	SLFN13 SLFN11	3.57e-04	3	205	2	IPR018647
Domain	Neural_cell_adh	NCAM1 HMCN1	7.09e-04	4	205	2	IPR009138
Domain	L-Aspartase-like	FH HAL	7.09e-04	4	205	2	IPR008948
Domain	Fumarase/histidase_N	FH HAL	7.09e-04	4	205	2	IPR024083
Domain	-	FH HAL	7.09e-04	4	205	2	1.10.275.10
Domain	VWA_2	INTS6L INTS6	1.17e-03	5	205	2	PF13519
Domain	IGv	OBSCN PVR NECTIN2 HSPG2 HMCN1	1.41e-03	75	205	5	SM00406
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MON2 DCAKD AGO2 PAK4 KPNA6 CUL7 WASHC5 UCHL5 CRLF3 RRP12 NECTIN2 SEC16A ANKRD28 ANKRD52 KPNA1 VAT1 KPNA3 KPNA4 RNF169 CCDC22 IPO7 KRT17 DUSP2 RALGAPB TTC27 CCT7 PPP2R1A NAT10 SLFN11 ATP2B1	2.95e-12	1049	214	30	27880917
Pubmed	Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	8.42e-12	5	214	5	17981117
Pubmed	Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	8551560
Pubmed	p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	2064827
Pubmed	Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	9548947
Pubmed	A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	9603322
Pubmed	CNI-H0294, a nuclear importation inhibitor of the human immunodeficiency virus type 1 genome, abrogates virus replication in infected activated peripheral blood mononuclear cells.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	9593140
Pubmed	HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	7585960
Pubmed	Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	9918876
Pubmed	HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	7859280
Pubmed	Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	9008157
Pubmed	Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocation.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	8876228
Pubmed	Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	7745752
Pubmed	The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	9557700
Pubmed	The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	8041786
Pubmed	The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	8041734
Pubmed	HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	9303297
Pubmed	Inhibition of nuclear import by backbone cyclic peptidomimetics derived from the HIV-1 MA NLS sequence.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	11904219
Pubmed	Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	8529100
Pubmed	A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signal.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	15037073
Pubmed	Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	5.03e-11	6	214	5	8659115
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	MON2 DCAKD ATP7B ELOVL5 KPNA6 INTS2 PVR HYLS1 FASTKD3 KPNA1 KPNA3 KPNA4 KPNA5 CCDC22 IPO7 RALGAPB TTC27 PPP2R1A PPT1 NINL BZW1 ATP2B1 WDTC1	3.57e-10	754	214	23	33060197
Pubmed	Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	4.64e-10	8	214	5	8552640
Pubmed	HIV-1 nuclear import: in search of a leader.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	10525473
Pubmed	Viral protein R regulates nuclear import of the HIV-1 pre-integration complex.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	9463369
Pubmed	Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	10366569
Pubmed	Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	12368302
Pubmed	Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	11035935
Pubmed	HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	9275210
Pubmed	The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	10888652
Pubmed	A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	8105392
Pubmed	HIV-1 infection requires a functional integrase NLS.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	11389849
Pubmed	Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	12414950
Pubmed	HIV-1 nuclear import: in search of a leader.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	9366553
Pubmed	Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	10860744
Pubmed	Active nuclear import of human immunodeficiency virus type 1 preintegration complexes.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	1631159
Pubmed	Characterization of the nuclear import pathway for HIV-1 integrase.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	1.04e-09	9	214	5	11278458
Pubmed	Cloning of two novel human importin-alpha subunits and analysis of the expression pattern of the importin-alpha protein family.	KPNA6 KPNA3 KPNA4 KPNA5	1.39e-09	4	214	4	9395085
Pubmed	Importin α3 regulates chronic pain pathways in peripheral sensory neurons.	KPNA6 KPNA1 KPNA3 KPNA4	1.39e-09	4	214	4	32792398
Pubmed	HIV-1 p17 and IFN-gamma both induce fructose 1,6-bisphosphatase.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	2.07e-09	10	214	5	9282826
Pubmed	The HIV-1 passage from cytoplasm to nucleus: the process involving a complex exchange between the components of HIV-1 and cellular machinery to access nucleus and successful integration.	KPNA1 KPNA3 KPNA4 KPNA5 IPO7	3.77e-09	11	214	5	22509482
Pubmed	HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	3.77e-09	11	214	5	9562972
Pubmed	Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	6.44e-09	12	214	5	7494303
Pubmed	Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal.	KPNA1 KPNA3 KPNA4 KPNA5	6.94e-09	5	214	4	19961612
Pubmed	Identification of novel homologues of mouse importin alpha, the alpha subunit of the nuclear pore-targeting complex, and their tissue-specific expression.	KPNA6 KPNA1 KPNA3 KPNA4	6.94e-09	5	214	4	9369227
Pubmed	Three distinct classes of the alpha-subunit of the nuclear pore-targeting complex (importin-alpha) are differentially expressed in adult mouse tissues.	KPNA6 KPNA1 KPNA3 KPNA4	2.07e-08	6	214	4	10026238
Pubmed	Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral preintegration complex.	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5	2.40e-08	15	214	5	10964507
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	DCAKD TCTN3 MAN2B1 FSTL3 ERAP1 ELOVL5 KIF4A HSPBP1 LPCAT2 RRP12 PVR NECTIN2 TMEM132A ADGRA3 TPST2 HSPG2 NCAPD3 COL12A1 H6PD CTSA ADAM22 PPT1 CTNNB1 ATP2B1 IL6ST SORL1	3.03e-08	1201	214	26	35696571
Pubmed	Evidence for distinct substrate specificities of importin alpha family members in nuclear protein import.	KPNA6 KPNA1 KPNA3 KPNA4	4.81e-08	7	214	4	10523667
Pubmed	Active nuclear import and cytoplasmic retention of activation-induced deaminase.	KPNA1 KPNA3 KPNA4 KPNA5	4.81e-08	7	214	4	19412186
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	TCTN3 MAN2B1 ERAP1 PVR HSPG2 ICAM1 MUC5B H6PD CTSA SORL1	8.11e-08	164	214	10	32409323
Pubmed	Nuclear translocation of hypoxia-inducible factors (HIFs): involvement of the classical importin alpha/beta pathway.	KPNA6 KPNA1 KPNA3 KPNA5	9.57e-08	8	214	4	18187047
Pubmed	Importin α7 is essential for zygotic genome activation and early mouse development.	KPNA6 KPNA1 KPNA3 KPNA4	9.57e-08	8	214	4	21479251
Pubmed	An actin-regulated importin α/β-dependent extended bipartite NLS directs nuclear import of MRTF-A.	KPNA6 KPNA3 KPNA4 KPNA5	9.57e-08	8	214	4	20818336
Pubmed	Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm.	KPNA1 KPNA3 KPNA4 KPNA5	9.57e-08	8	214	4	20015032
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	PAK4 C2CD5 EHBP1L1 CYFIP1 LPCAT2 NECTIN2 STX7 VAT1 ICAM1 RP2 CTNNB1 PCDH1 ATP2B1 IL6ST	1.08e-07	377	214	14	38117590
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MON2 AGO2 ATP7B EARS2 KPNA6 CUL7 C2CD5 SEC16A ANKRD28 MGA ANKRD52 NOVA2 KPNA1 KPNA3 AOX1 TTC27 INTS6 RESF1 NAT10 SLFN11 PHF10 GARRE1 SORL1 WDTC1	1.21e-07	1116	214	24	31753913
Pubmed	14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1).	KPNA1 KPNA3 KPNA4 KPNA5	1.71e-07	9	214	4	15057270
Pubmed	Changing expression and subcellular distribution of karyopherins during murine oogenesis.	KPNA6 KPNA1 KPNA3 KPNA4	1.71e-07	9	214	4	26399853
Pubmed	Transportin 3 and importin α are required for effective nuclear import of HIV-1 integrase in virus-infected cells.	KPNA1 KPNA3 KPNA4 KPNA5	1.71e-07	9	214	4	21326825
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	MON2 KPNA6 HSPBP1 C2CD5 CYFIP1 SEC16A ANKRD28 ANKRD52 KPNA1 KPNA5 CARM1 NCAPD3 IPO7 DUSP2 TTC27 CCT7 CPOX PPP2R1A PPP2R1B BZW1 ATP2B1 SORL1	1.84e-07	974	214	22	28675297
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MON2 DCAKD TCTN3 SPAG1 PAK4 ELOVL5 BBS4 HSPBP1 BBS9 CYFIP1 NECTIN2 SEC16A ANKRD28 KPNA3 KPNA4 CTSA PPP2R1A TTC21B NINL RP2 BZW1 QSER1 CTNNB1 RASSF8 SORL1 WDTC1	1.95e-07	1321	214	26	27173435
Pubmed	KIF4 mediates anterograde translocation and positioning of ribosomal constituents to axons.	RPLP0 KIF4A KIF4B	2.30e-07	3	214	3	19158085
Pubmed	Importin alpha nuclear localization signal binding sites for STAT1, STAT2, and influenza A virus nucleoprotein.	KPNA1 KPNA3 KPNA5	2.30e-07	3	214	3	12740372
Pubmed	Differential use of importin-α isoforms governs cell tropism and host adaptation of influenza virus.	KPNA6 KPNA1 KPNA3	2.30e-07	3	214	3	21245837
Pubmed	Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.	AGO2 KPNA6 NCR3LG1 C2CD5 ANKRD28 ANKRD52 KPNA1 VAT1 KPNA3 KPNA4 KPNA5 CARM1 CTSA PPT1 BZW1 IL6ST	2.38e-07	533	214	16	25544563
Pubmed	SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia.	KPNA6 KPNA1 KPNA3 KPNA4	2.84e-07	10	214	4	35021089
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	PAK4 OBSCN BBS4 PTGS2 C2CD5 PHC3 INTS2 SEC16A ZBTB40 MGA USP3 KPNA3 RASA2 ATXN1L CD160 RESF1 TET1 NAT10 IRAK4 RP2 QSER1 DOT1L ATP2B1	2.86e-07	1084	214	23	11544199
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	MON2 MAN2B1 RPLP0 KPNA6 HSPBP1 COG3 EHBP1L1 CYFIP1 WASHC5 UCHL5 SEC16A ANKRD28 PLCB3 FH KPNA1 VAT1 KPNA3 KPNA4 CARM1 IPO7 KRT17 COPB1 CCT7 CTSA PPP2R1A PPP2R1B BZW1	3.54e-07	1455	214	27	22863883
Pubmed	A nonconventional nuclear localization signal within the UL84 protein of human cytomegalovirus mediates nuclear import via the importin alpha/beta pathway.	KPNA1 KPNA4 KPNA5	9.15e-07	4	214	3	12610148
Pubmed	Molecular determinants for nuclear import of influenza A PB2 by importin α isoforms 3 and 7.	KPNA6 KPNA1 KPNA4	9.15e-07	4	214	3	25599645
Pubmed	MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection.	KPNA1 KPNA3 KPNA4	9.15e-07	4	214	3	29370303
Pubmed	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response.	KPNA6 KPNA1 KPNA3 KPNA4	9.54e-07	13	214	4	34950606
Pubmed	Defining the membrane proteome of NK cells.	DCAKD AGO2 ATP7B RPLP0 ERAP1 ELOVL5 KIF4A NCAM1 KPNA6 ITGAL EHBP1L1 INTS2 NCAPD3 IPO7 COPB1 ICAM1 CTSA PPT1 NAT10 HELZ2 BZW1 ATP2B1 IL6ST	1.03e-06	1168	214	23	19946888
Pubmed	Regulating the functions of the HIV-1 matrix protein.	KPNA1 KPNA3 KPNA4 KPNA5	1.33e-06	14	214	4	17411366
Pubmed	Identification of domains of ataxia-telangiectasia mutated required for nuclear localization and chromatin association.	KPNA1 KPNA3 KPNA5	2.28e-06	5	214	3	15929992
Pubmed	Importin α5 Regulates Anxiety through MeCP2 and Sphingosine Kinase 1.	KPNA6 KPNA1 KPNA3	2.28e-06	5	214	3	30540948
Pubmed	Transport of hypoxia-inducible factor HIF-1alpha into the nucleus involves importins 4 and 7.	KPNA6 KPNA4 IPO7	2.28e-06	5	214	3	19788888
Pubmed	Nuclear localization of Duplin, a beta-catenin-binding protein, is essential for its inhibitory activity on the Wnt signaling pathway.	KPNA1 KPNA3 CTNNB1	2.28e-06	5	214	3	11744694
Pubmed	Human transcription factor protein interaction networks.	SOX5 AGO2 CUL7 PHC3 UCHL5 RRP12 SEC16A ZBTB40 ANKRD28 MGA HSPG2 COPB1 CCT7 ATXN1L PPP2R1A RESF1 NAT10 ELF1 QSER1 HAL RASSF8 DOT1L PHF10 GARRE1 SORL1	2.84e-06	1429	214	25	35140242
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYOM1 OBSCN GSDME ZBTB40 ANKRD28 MGA HSPG2 COL12A1 IPO7 KRT17 KALRN HOOK3 C1QTNF9 IL6ST	2.88e-06	497	214	14	23414517
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	MON2 AGO2 RPLP0 EARS2 KPNA6 CYFIP1 UCHL5 SEC16A KPNA1 VAT1 KPNA3 KPNA5 CARM1 NCAPD3 IPO7 COPB1 TTC27 CCT7 CPOX PPP2R1A PPP2R1B PPT1 CTNNB1	3.51e-06	1257	214	23	37317656
Pubmed	Regulation of cellular adhesion molecule expression in murine oocytes, peri-implantation and post-implantation embryos.	NCAM1 ITGAL ICAM1	4.53e-06	6	214	3	12528895
Pubmed	Retinoblastoma-binding Protein 4-regulated Classical Nuclear Transport Is Involved in Cellular Senescence.	KPNA1 KPNA3 KPNA5	4.53e-06	6	214	3	26491019
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	PAK4 CUL7 C2CD5 CRLF3 SEC16A ANKRD28 ANKRD52 RALGAPB PPP2R1A NINL CTNNB1 RASSF8 GARRE1	4.54e-06	446	214	13	24255178
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	PAK4 KIF4A DDX4 HSPG2 COPB1 CCT7 TET1 KIF4B CTNNB1	5.14e-06	203	214	9	22083510
Pubmed	Streamlined analysis schema for high-throughput identification of endogenous protein complexes.	INTS2 INTS6L MED30 PPP2R1A PPP2R1B INTS6	5.19e-06	71	214	6	20133760
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	MON2 EARS2 KPNA6 HSPBP1 RRP12 ANKRD28 ANKRD52 KPNA1 VAT1 KPNA3 KPNA5 NCAPD3 COPB1 TTC27 VPS13D	6.06e-06	606	214	15	36538041
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	SOX5 ALDH1L1 PHC3 SEC16A MGA KPNA3 KPNA4 IPO7 PCLO RESF1 SLFN11 DOT1L	7.57e-06	398	214	12	35016035
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	AGO2 KIF4A NCAM1 CYFIP1 SEC16A ANKRD28 MGA KPNA1 TRIM46 CARM1 KALRN NTRK2 ADAM22 PPP2R1A HOOK3 NAT10 KIF4B QSER1 CTNNB1	9.15e-06	963	214	19	28671696
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	FSTL3 PVR ZBTB40 PGS1 KALRN NTRK2 ZSWIM6 ATXN1L KRT23 INTS6 HELZ2 CKAP2L DBR1 GARRE1	9.48e-06	552	214	14	10737800
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MON2 DCAKD ELOVL5 COG3 RRP12 ANKRD28 STX7 ALPP KPNA3 NCAPD3 CCDC22 IPO7 COPB1 TTC27 CCT7 CTSA PPP2R1A PPP2R1B HOOK3 NAT10 BZW1 CTNNB1 ATP2B1 GARRE1	1.02e-05	1440	214	24	30833792
Pubmed	A protein interaction landscape of breast cancer.	RPLP0 ERAP1 KPNA6 HSPBP1 CUL7 ANKRD28 KPNA1 KPNA3 KPNA4 ICAM1 MUC5B CTSA NAT10 CTNNB1 PHF10	1.03e-05	634	214	15	34591612
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	TCTN3 RPLP0 OBSCN HSPBP1 LPCAT2 SEC16A FH VAT1 IPO7 KRT17 TTC27 VPS13D FRRS1 HAL	1.20e-05	564	214	14	21565611
Pubmed	BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells.	KPNA6 KPNA1 KPNA5	1.26e-05	8	214	3	26052702
Pubmed	Sensitivity of dendritic cells to NK-mediated lysis depends on the inflammatory environment and is modulated by CD54/CD226-driven interactions.	PVR NECTIN2 ICAM1	1.26e-05	8	214	3	27034402
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	KPNA6 UCHL5 RRP12 ANKRD52 KPNA1 KPNA3 KPNA4 CARM1 IPO7 COPB1 CPOX PPP2R1A CTNNB1 WDTC1	1.38e-05	571	214	14	37167062
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	CYFIP1 RRP12 SEC16A KPNA1 KPNA4 KPNA5 IPO7 COPB1 PCLO PPP2R1A PPP2R1B NAT10 CTNNB1	1.47e-05	498	214	13	36634849
Pubmed	The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer.	INTS2 PPP2R1A PPP2R1B INTS6	1.59e-05	25	214	4	34004147
Pubmed	Congenital Hepatic Fibrosis Overview ─ RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	TCTN3 BBS4 BBS9 PKHD1 TTC21B	1.73e-05	52	214	5	20301743
GeneFamily	Armadillo repeat containing\|Importins	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5 IPO7	4.84e-09	18	149	6	596
GeneFamily	Immunoglobulin like domain containing	IL1RL2 TYRO3 FCGR2A PVR NECTIN2 NCR1 HSPG2 TMIGD2 ICAM1 ADAMTSL3 ADGRA2 CD160	6.89e-08	193	149	12	594
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MYOM1 OBSCN NCAM1 TYRO3 ADGRA3 HSPG2 KALRN NTRK2 ADAMTSL3 HMCN1	8.95e-07	161	149	10	593
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	KPNA6 KPNA1 KPNA3 KPNA4 KPNA5 CTNNB1	1.34e-06	43	149	6	409
GeneFamily	Fibronectin type III domain containing	MYOM1 OBSCN NCAM1 TYRO3 CRLF3 COL12A1 KALRN IL6ST SORL1	7.20e-06	160	149	9	555
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	NCAM1 TLR6 ITGAL FCGR2A PVR NECTIN2 NCR2 NCR1 LILRA5 ICOSLG ICAM1 CD160 IL6ST	2.36e-05	394	149	13	471
GeneFamily	Protein phosphatase 2 scaffold subunits\|STRIPAK complex	PPP2R1A PPP2R1B	6.75e-05	2	149	2	1266
GeneFamily	Immunoglobulin like domain containing\|Adhesion G protein-coupled receptors, subfamily A	ADGRA3 ADGRA2	2.01e-04	3	149	2	911
GeneFamily	Integrator complex	INTS2 INTS6L INTS6	2.32e-04	15	149	3	1366
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	SPAG1 BBS4 TTC27 TTC21B CFAP46 WDTC1	3.81e-04	115	149	6	769
GeneFamily	Ankyrin repeat domain containing	ANKLE1 ANKRD28 ANKRD52 ACAP3 ANKRD42 ASZ1 ASB13 POTEA	9.05e-04	242	149	8	403
GeneFamily	Protein phosphatase 6 regulatory subunits	ANKRD28 ANKRD52	9.90e-04	6	149	2	699
GeneFamily	Schlafen family	SLFN13 SLFN11	1.38e-03	7	149	2	1110
GeneFamily	Bardet-Biedl syndrome associated\|BBSome	BBS4 BBS9	1.83e-03	8	149	2	1122
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	PVR NECTIN2 ICOSLG	4.34e-03	40	149	3	592
Coexpression	NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP	MON2 TCTN3 TLR6 BBS9 PTGS2 ZBTB40 FASTKD3 VAT1 IPO7 DUSP2 TTC27 ADGRA2 ASB13 RESF1 HAL	8.29e-06	477	211	15	M40930
Coexpression	HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN	MAN2B1 TRPC1 TLR6 ST14 CYFIP1 FCGR2A FES KCNMB4 VAT1 CTSA ADGRA2 ADAM22 ASB13 PPT1 ASGR1 HAL PCDH1 ATP2B1 SORL1	9.53e-06	740	211	19	M41202
Coexpression	ZHONG_PFC_MAJOR_TYPES_MICROGLIA	MAN2B1 TMC6 CYFIP1 LPCAT2 FCGR2A FES TMIGD2 ARHGAP9 CTSA PPT1 LPIN2 ELF1 IL6ST SORL1	1.39e-05	438	211	14	M39077
Coexpression	HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE	TMEM88 SOX5 MAN2B1 PAK4 ANKLE1 TLR6 PTGS2 ST14 RRP12 USP3 KPNA3 CARM1 HSPG2 ICOSLG ICAM1 LRRC58 ADGRA2 KRT23 FRRS1 ELF1 RP2 BZW1 HAL RASSF8 DOT1L	2.72e-05	1250	211	25	M41099
Coexpression	GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	EARS2 ELOVL5 ITGAL CYFIP1 LPCAT2 INTS2 FES TPST2 ATP2B1	3.74e-05	200	211	9	M9496
Coexpression	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP	SPAG1 MAN2B1 ST14 FES DDX4 RASA2 ICAM1 IRAK4 SLC28A2	3.74e-05	200	211	9	M4561
Coexpression	GSE339_CD4POS_VS_CD8POS_DC_UP	TLR6 BBS9 PTGS2 CYFIP1 FH IPO7 ARHGAP9 CTSA LPIN2	3.74e-05	200	211	9	M5108
Coexpression	GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN	MAN2B1 KIF4A ZNF215 CYFIP1 UCHL5 COPB1 FRRS1 SLFN13 SLFN11	3.74e-05	200	211	9	M9240
ToppCell	ILEUM-inflamed-(6)_ILC\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NCAM1 FES NCR2 NCR1 RASA2 TMIGD2 DUSP2 CD160 BZW1 CTNNB1 RASSF8	2.67e-09	194	213	11	4d51d49366c34ff1241770b4acc0167a43b3155a
ToppCell	10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-\|blood / Manually curated celltypes from each tissue	SPAG1 NCAM1 NCR1 ADGRA3 DUSP2 ICAM1 ARHGAP9 CD160 SLFN13 RASSF8	8.00e-09	166	213	10	ba42349a68b22e91a0340bda1ccecd6c7592392f
ToppCell	ILEUM-non-inflamed-(6)_ILC3\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ELOVL5 PTGS2 NECTIN2 FES NCR2 RASA2 TMIGD2 BZW1 CTNNB1 RASSF8	3.05e-08	191	213	10	6eaf72b41084404bee0db04e4605db745a74995f
ToppCell	background-NK_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	NCAM1 ITGAL NCR1 RASA2 TMIGD2 DUSP2 ARHGAP9 TSPAN5 CD160 SLFN13	3.36e-08	193	213	10	f8d6eff1e04926f85d265ec39fe66897fe29574d
ToppCell	(0)_NK/T_cells-(0)_NK_T_CD8_Cytotoxic\|(0)_NK/T_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	SPAG1 NCAM1 PTGS2 FES NCR1 TMIGD2 DUSP2 ICAM1 CD160 SLFN13	3.70e-08	195	213	10	13717c6e42882162445bc1b1445d66efcb68e19d
ToppCell	ILEUM-non-inflamed-(6)_ILC\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NCAM1 PTGS2 NCR2 NCR1 RASA2 TMIGD2 CD160 BZW1 CTNNB1 RASSF8	4.08e-08	197	213	10	76a233eb9611d24b9bb9f4359c26606332a3c29e
ToppCell	10x5'-Lung-Lymphocytic_NK-NK_CD56bright_CD16-\|Lung / Manually curated celltypes from each tissue	NCAM1 NCR1 RASA2 TMIGD2 ARHGAP9 ADAM22 CD160 SLFN13 SMCR5	7.76e-08	159	213	9	595643e9433265308e5aab7f906229025701cf6a
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPC1 CUL7 ZBTB40 ANKRD28 MGA ACAP3 RALGAPB C1QTNF9 IL6ST	2.13e-07	179	213	9	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	mild_COVID-19-NK_CD56bright\|mild_COVID-19 / disease group, cell group and cell class (v2)	SPAG1 NCAM1 FES NCR1 TPST2 DUSP2 ICAM1 SLFN13 RASSF8	2.24e-07	180	213	9	d8b418edd807a51c0b5f4018b8b478dcc65892a7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN OBSCN PKHD1 COL12A1 KALRN PCLO MUC5B HMCN1 HYDIN	2.69e-07	184	213	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN OBSCN PKHD1 COL12A1 KALRN PCLO MUC5B HMCN1 HYDIN	2.69e-07	184	213	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN OBSCN PKHD1 COL12A1 KALRN PCLO MUC5B HMCN1 HYDIN	2.69e-07	184	213	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NCAM1 NCR1 TPST2 TMIGD2 DUSP2 CD160 SLFN13 KCTD10 RASSF8	2.95e-07	186	213	9	5ad37549592eab23f166196ebf0cb9c8ddf26082
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|lymph-node_spleen / Manually curated celltypes from each tissue	FSTL3 EARS2 KIF4A PTGS2 RRP12 SEC16A LILRA5 ADGRA2 QSER1	3.09e-07	187	213	9	3c10b8501226c69d71bcd99dc1c064a3c2154f87
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-\|bone_marrow / Manually curated celltypes from each tissue	NCAM1 NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13 RASSF8	3.38e-07	189	213	9	6e402fb3fc31e4cb541e3cd140d7a86c1083dbf5
ToppCell	Immune-natural_killer_cell\|World / Lineage, Cell type, age group and donor	NCAM1 ITGAL NCR1 RASA2 DUSP2 ARHGAP9 CD160 SLFN13 SORL1	3.86e-07	192	213	9	68121a6ef4115a93d87aad8802ef9b27d793d8c0
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	NCAM1 ITGAL NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	4.03e-07	193	213	9	e790ab76c12f74a13936c231076f1e397283efb3
ToppCell	ILEUM-non-inflamed-(6)_ILC1\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NCAM1 NCR1 RASA2 TMIGD2 DUSP2 ICAM1 ARHGAP9 CD160 SLFN13	4.21e-07	194	213	9	396f9a6b370721d425cbe335dbeea5f9514c92dc
ToppCell	ILEUM-inflamed-(6)_ILC1\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TCTN3 NCAM1 NCR1 RASA2 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	4.21e-07	194	213	9	dc9ca407ec3ebec1a3dea1213a2beef28c1dc043
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	NCAM1 ITGAL NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	4.21e-07	194	213	9	7773501e076d470158dbc1d7f10c67152b326eb7
ToppCell	10x5'-Liver-Lymphocytic_NK\|Liver / Manually curated celltypes from each tissue	NCAM1 NCR1 TPST2 TMIGD2 ARHGAP9 CD160 SLFN13 KCTD10 SORL1	4.21e-07	194	213	9	0b78f4ed84bbaca9f72f005c16c7492bb01d4328
ToppCell	PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CXorf65 NCR1 DDX4 DUSP2 TAFA3 ARHGAP9 LRRC58 CD160	4.31e-07	142	213	8	c2a3cd9998fd9a8e6b2665347ca5c32511776488
ToppCell	T/NK_cells-CD56bright_NK_cell\|T/NK_cells / Lineage and Cell class	NCAM1 FES NCR1 TPST2 TMIGD2 ICAM1 ARHGAP9 CD160 SLFN13	4.39e-07	195	213	9	d2c8f5c114b1864b509fad449aa4492dfc61113c
ToppCell	3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-\|blood / Manually curated celltypes from each tissue	SPAG1 AGO2 NCAM1 DUSP2 ICAM1 INTS6 SLFN13 BZW1 RASSF8	4.39e-07	195	213	9	1470f562ebcfe7da367964ecfd6c7f43bcdb4a73
ToppCell	3'_v3-blood-Lymphocytic_NK\|blood / Manually curated celltypes from each tissue	NCAM1 ITGAL NCR1 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13 BZW1	4.39e-07	195	213	9	731a454e45c7b610e0140312bcabaea711dcc766
ToppCell	ILEUM-inflamed-(6)_ILC3\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NCAM1 FES NCR2 MPPED2 RASA2 TMIGD2 BZW1 CTNNB1 RASSF8	4.39e-07	195	213	9	c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed
ToppCell	normal_Lymph_Node-T/NK_cells-NK\|normal_Lymph_Node / Location, Cell class and cell subclass	NCAM1 FES NCR1 TPST2 TMIGD2 DUSP2 ICAM1 CD160 SLFN13	4.59e-07	196	213	9	00ab4a1547752d419aa720b39b94a4ab2ede963a
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK\|lymph-node_spleen / Manually curated celltypes from each tissue	NCAM1 NCR1 TPST2 TMIGD2 DUSP2 ICAM1 ARHGAP9 CD160 SLFN13	4.59e-07	196	213	9	93ff94fc2b2ca8bd6a6492cbc0b402daf5d63ea2
ToppCell	10x5'-Liver-Lymphocytic_NK-NK_CD56bright_CD16-\|Liver / Manually curated celltypes from each tissue	SPAG1 NCAM1 NCR1 TMIGD2 ICAM1 ARHGAP9 CD160 SLFN13 KCTD10	4.59e-07	196	213	9	4ad73515af265432235b698fceb0ba370ced3e52
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NCAM1 NCR2 NCR1 RASA2 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	4.79e-07	197	213	9	e8861abffbb7169f1923fad6e565865eee22f310
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NCAM1 ITGAL NCR1 RASA2 TMIGD2 DUSP2 ARHGAP9 CD160 SORL1	5.43e-07	200	213	9	d1cfc4ef6ae75c486427e393d98b84a2a7ec67fe
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-NK\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	NCAM1 ITGAL NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160 SORL1	5.43e-07	200	213	9	85bb2f4c97b03258615bc09279c70766c99ec942
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NCAM1 NCR1 ADGRA3 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	1.41e-06	166	213	8	61e4b2d2db093e64f7354b534aa8571803a3bd44
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-NK_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGAL NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	1.47e-06	167	213	8	2ca1b994583edf4e197535ffac8fb0c1142f0dc1
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD56bright_CD16-\|GI_small-bowel / Manually curated celltypes from each tissue	NCAM1 DCST1 TMEM132A NCR1 DUSP2 ARHGAP9 SLFN13 RASSF8	1.47e-06	167	213	8	7ff186b2bed3b0de93addb3b0ae5a2c6e44ddfb2
ToppCell	COVID-19_Severe-NK_CD56bright\|COVID-19_Severe / Disease condition and Cell class	SPAG1 NCAM1 FES NCR2 NCR1 DUSP2 SLFN13 RASSF8	1.75e-06	171	213	8	5810f790012a0750ca3378595514f66a99f123be
ToppCell	COVID-19_Moderate-NK_CD56bright\|COVID-19_Moderate / disease group, cell group and cell class	SPAG1 NCAM1 NCR1 TPST2 DUSP2 ARHGAP9 SLFN13 RASSF8	1.91e-06	173	213	8	a07dcb1e555caaa2235aec219334fcbf2d07f10c
ToppCell	Healthy/Control-NK_CD56bright\|Healthy/Control / Disease group and Cell class	SPAG1 NCAM1 NCR3LG1 NCR1 TMIGD2 DUSP2 SLFN13 RASSF8	2.00e-06	174	213	8	f53f675c8cb14294ac526dcc3dca4f08288f8473
ToppCell	COVID-19_Mild-NK_CD56bright\|COVID-19_Mild / Disease condition and Cell class	SPAG1 NCAM1 FES NCR1 TPST2 DUSP2 ICAM1 RASSF8	2.47e-06	179	213	8	90e7a4af195aa2332b07a9f06cde63e72ff49255
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-NK_T_cell\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FES NCR2 NCR1 TMIGD2 ARHGAP9 TSPAN5 CD160 SLFN13	2.68e-06	181	213	8	ee1c5af8ed75dd8a0ed3152ba5b9a42d2a8c2ae4
ToppCell	mild_COVID-19-NK_CD56bright\|World / disease group, cell group and cell class (v2)	SPAG1 NCAM1 NCR1 TPST2 DUSP2 ICAM1 SLFN13 RASSF8	2.91e-06	183	213	8	9a4899afac0f91203209392c5f67b3d0aa356b86
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-NK_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NCAM1 ITGAL NCR1 RASA2 TMIGD2 DUSP2 ARHGAP9 CD160	2.91e-06	183	213	8	b902390614fe924d48511e4187b36a0b49b08f23
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	MAS1L NTRK2 ABCC9 ADAMTSL3 ADAM22 HMCN1 RASSF8 IL6ST	3.03e-06	184	213	8	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK_CD56bright\|COVID-19_Mild / Disease group, lineage and cell class	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 SLFN13 RASSF8	3.03e-06	184	213	8	f67308228bb6a5d624279fbb04db25a2f4087c9b
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 SLFN13 RASSF8	3.15e-06	185	213	8	df5d2309d19ac8d5e429afa785d0a480e75a8f9e
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 SLFN13 RASSF8	3.15e-06	185	213	8	3a046c948524e5d0e986cd645e318d6930d7e0ee
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NCAM1 NCR1 TPST2 TMIGD2 DUSP2 CD160 SLFN13 RASSF8	3.15e-06	185	213	8	3b2da51aec057b462749ae39afb8f253afcf38d5
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 SLFN13 RASSF8	3.15e-06	185	213	8	71d1a771026d9fa3528d46ac3d11353e396f2d87
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 SLFN13 RASSF8	3.15e-06	185	213	8	37b48218dd523049b57b13eb9cdb34e106cf91ea
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-\|lymph-node_spleen / Manually curated celltypes from each tissue	NCAM1 NCR1 TMIGD2 DUSP2 ICAM1 ARHGAP9 CD160 SLFN13	3.41e-06	187	213	8	9000241566f48e435db9409b7255db68b68f6059
ToppCell	Healthy_donor-NK_CD56bright\|World / disease group, cell group and cell class (v2)	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 SLFN13 RASSF8	3.55e-06	188	213	8	8ee359199c61c3b5b498ac35148390db5cc1a836
ToppCell	cellseq-Immune-Hematopoietic-Granulocytic-Neutrophil\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TLR6 PTGS2 LPCAT2 FCGR2A LILRA5 ARHGAP9 RESF1 SORL1	3.69e-06	189	213	8	fedab592be1d6520325b8c1b659b0a4dc3f4fe4d
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ITGAL NCR1 RASA2 DUSP2 ARHGAP9 CD160 SLFN13 SORL1	3.69e-06	189	213	8	c604da558c9f4055fb36218452463539f2a73223
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PTGS2 LPCAT2 FCGR2A LILRA5 PGS1 ICAM1 KRT23 HAL	3.69e-06	189	213	8	235c24eeab5139f5821fccd5c879d8787682f4ef
ToppCell	Healthy_donor-NK_CD56bright\|Healthy_donor / disease group, cell group and cell class (v2)	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 SLFN13 RASSF8	3.69e-06	189	213	8	9eac380a3bb4b685effb52d816e1960972660646
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-NK_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NCAM1 NCR1 RASA2 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	3.69e-06	189	213	8	5a9c3c61998efc40a5d2042e0f568b52103734a9
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RELN NCAM1 FCGR2A KALRN PCLO ADAMTSL3 TSPAN5 NINL	3.84e-06	190	213	8	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 SLFN13	3.99e-06	191	213	8	7a4fe96989f72159385270c712342ba3e1ca6fc3
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NCAM1 ITGAL NCR1 RASA2 TMIGD2 CD160 SLFN13 SORL1	3.99e-06	191	213	8	9b8b64a36e27a2523b8730c7922fd7ad865a021e
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 SLFN13	3.99e-06	191	213	8	c023ca893ceae19b54967096f6e2588dc39fa268
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 SLFN13	3.99e-06	191	213	8	f1935e8f8467a2bc30588b7f2cc3b94e9c83b268
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 SLFN13	3.99e-06	191	213	8	1161e465c50c2071764279e01cf08b1048cce0e3
ToppCell	3'_v3-Lung-Lymphocytic_NK-NK_CD56bright_CD16-\|Lung / Manually curated celltypes from each tissue	SPAG1 NCAM1 NCR1 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	3.99e-06	191	213	8	12ce360dc149c85d5a22cfc1bf53d54aef79edc1
ToppCell	Control-Lymphoid_T/NK-NK_CD56bright\|Control / Disease group, lineage and cell class	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 SLFN13	3.99e-06	191	213	8	e842f29bc03ed6734b2a7b975e7830a498f2743c
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NCAM1 ITGAL NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160	4.15e-06	192	213	8	0cada869e852d4b9a60e95886c927fc24d072364
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NCAM1 ITGAL NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160	4.15e-06	192	213	8	de937cc101a654c6699090beb7e24c430d5a19bf
ToppCell	T/NK_cells-CD56bright_NK_cell\|World / Lineage and Cell class	NCAM1 NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	4.15e-06	192	213	8	528b5b790a0e8966d04ffbc83b049c93bac17537
ToppCell	droplet-Heart-HEART-1m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM88 NOVA2 TPST2 HSPG2 C1QTNF9 SLC28A2 CTNNB1 GARRE1	4.15e-06	192	213	8	9da21ce330f3b5661f159cf18d1c3e5ccc11d6dd
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DLG5 NCAM1 NCR1 TMIGD2 DUSP2 CD160 SLFN13 RASSF8	4.15e-06	192	213	8	df4741e7684f010445f0224a1fd61aaa4fae02b3
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NCAM1 ITGAL NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160	4.15e-06	192	213	8	f1a843e22bdef9fdc063c21f096269eb4af590a8
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-NK_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGAL NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	4.31e-06	193	213	8	044fba87c4d10f4943a9f57315920280a4d097e7
ToppCell	Control-NK_CD56bright\|Control / Disease condition and Cell class	SPAG1 NCAM1 FES NCR1 TPST2 ICAM1 SLFN13 RASSF8	4.31e-06	193	213	8	8b1e7a226a6057e1097c1525984127b54e823876
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK\|lymph-node_spleen / Manually curated celltypes from each tissue	NCAM1 ITGAL NCR1 TPST2 TMIGD2 ARHGAP9 CD160 SLFN13	4.31e-06	193	213	8	e325cf49e159c6be205ed93adaa09efdd0c122b4
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NCR2 NCR1 TMIGD2 ARHGAP9 CD160 RESF1 LPIN2 ELF1	4.31e-06	193	213	8	544de0988510cc57744710d7cafe07aa27a0b99d
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NCAM1 ITGAL NCR1 RASA2 TMIGD2 CD160 SLFN13 SORL1	4.31e-06	193	213	8	1cb666375bc4e1b11a146d20896c9b5ae6fd0887
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-\|bone_marrow / Manually curated celltypes from each tissue	NCAM1 NCR1 TMIGD2 DUSP2 ICAM1 ARHGAP9 CD160 SLFN13	4.48e-06	194	213	8	5c58a2d1dd3c8ff77ce44d473239685e6b020909
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 CD160 SLFN13	4.48e-06	194	213	8	aee60da2e7aed161cdd4abbfad6864665aaa8f5c
ToppCell	3'_v3-Lung-Lymphocytic_NK-NK_CD16\|Lung / Manually curated celltypes from each tissue	NCAM1 ITGAL NCR1 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	4.48e-06	194	213	8	3337042eef91a49f621058785723228cf4dfdad4
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SPAG1 NCAM1 NCR1 TPST2 TMIGD2 DUSP2 CD160 SLFN13	4.48e-06	194	213	8	afa8d29924719af3bc5f48f22cf66d5e8f9e3e37
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-\|lymph-node_spleen / Manually curated celltypes from each tissue	NCAM1 NCR1 TMIGD2 DUSP2 ICAM1 ARHGAP9 CD160 SLFN13	4.48e-06	194	213	8	8a596f25f6bfa5baaa2f52d80ad92f2925713398
ToppCell	(0)_NK_T_CD8_Cytotoxic\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	NCAM1 ITGAL NCR2 NCR1 TMIGD2 DUSP2 ARHGAP9 CD160	4.65e-06	195	213	8	47efd6531a8421c733fabd905c71a7976d43f1ae
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAK4 NCAM1 MPPED2 VAT1 COL12A1 ICAM1 FRRS1 PCDH1	4.65e-06	195	213	8	cad21edd90bf3e2fefdf5773a59cb1a664a69ddd
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NCAM1 NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	4.65e-06	195	213	8	72f42f0be53a2a61f61647118b4883e752d998a5
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ITGAL NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	4.83e-06	196	213	8	9bb87d20c25df0dc8e48bcb32b57f81a3dc1c0cd
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PVR HSPG2 IPO7 COPB1 LRRC58 BZW1 CTNNB1 IL6ST	4.83e-06	196	213	8	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	(0)_NK_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	NCAM1 ITGAL NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160	4.83e-06	196	213	8	9b080859130cf156bfa833dc71fd39734cb9a32d
ToppCell	(0)_NK\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	NCAM1 ITGAL NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160	4.83e-06	196	213	8	e2578a562d9903a33a7c60db229005680af8141c
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo\|GI_small-bowel / Manually curated celltypes from each tissue	FES NCR2 NCR1 TMIGD2 ARHGAP9 CD160 SLFN13 CTNNB1	4.83e-06	196	213	8	a54ec174461944229c98a0b48b4822a556191ccb
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|GI_small-bowel / Manually curated celltypes from each tissue	FES NCR2 NCR1 TMIGD2 ARHGAP9 CD160 SLFN13 CTNNB1	4.83e-06	196	213	8	84cab9390794fe50203834b745722bf11c208ebd
ToppCell	normal_Lung-T/NK_cells-NK\|normal_Lung / Location, Cell class and cell subclass	NCAM1 NCR1 TPST2 TMIGD2 DUSP2 ARHGAP9 CD160 SORL1	5.01e-06	197	213	8	6045a05a5f1073d683806eb46a3fa98358414625
ToppCell	background-NK_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	NCAM1 ITGAL NCR1 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	5.01e-06	197	213	8	e8e1d3e557fe821efe81012e759e35e4ae33ce86
ToppCell	tumor_Lung-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	NCAM1 FES NCR1 TPST2 TMIGD2 DUSP2 CD160 SLFN13	5.01e-06	197	213	8	e9fac2c923179b2b8b0500076421c6fb09960b56
ToppCell	control-Myeloid-Non-resident_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MON2 FCGR2A USP3 RASA2 ZSWIM6 LPIN2 ATP2B1 SORL1	5.01e-06	197	213	8	df2fe36cb96e2565a9d21c24cb4e451e8befd4be
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	NCAM1 ITGAL NCR1 TMIGD2 DUSP2 ARHGAP9 CD160 SLFN13	5.01e-06	197	213	8	a97c4a9eb89260b0b5745834ccef9d558d857f93
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NCAM1 ITGAL NCR1 TPST2 TMIGD2 ARHGAP9 CD160 SLFN13	5.20e-06	198	213	8	eb5407908f1e43b5775d50006cc6c71e90b73660
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NCAM1 ITGAL NCR1 TPST2 TMIGD2 ARHGAP9 CD160 SLFN13	5.20e-06	198	213	8	56a39e44c6f97b8093e3a3815b94a1ddf906f59d
ToppCell	normal_Lymph_Node-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	NCAM1 FES NCR1 TPST2 DUSP2 ICAM1 CD160 SLFN13	5.20e-06	198	213	8	75e94298bf03d755fef46df685437d0d29fdbca9
ToppCell	(0)_NK_cell\|World / shred on Cell_type and subtype	NCAM1 NCR1 TMIGD2 DUSP2 ICAM1 ARHGAP9 CD160 SLFN13	5.20e-06	198	213	8	dd8d5d635df7d4875c7a19f605e1289bc66bcfa6
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK\|COVID-19_Mild / Disease group, lineage and cell class	NCAM1 ITGAL NCR1 TPST2 TMIGD2 ARHGAP9 CD160 SLFN13	5.20e-06	198	213	8	52f9ed4b89bbce53104179bee194c0456c4b7a3c
ToppCell	severe-Lymphocytic-NK_cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	NCAM1 ITGAL NCR1 TPST2 DUSP2 CD160 SLFN13 KCTD10	5.20e-06	198	213	8	6ef22f33b43e9adceea11738e3cba0e8b59b4ec6
Drug	HYCRON linker	KPNA1 KPNA3 KPNA4 KPNA5	3.30e-08	5	207	4	CID011069636
Drug	CNI-H0294	KPNA1 KPNA3 KPNA4 KPNA5	3.30e-08	5	207	4	CID000073088
Drug	AC1LA3FM	KPNA1 KPNA3 KPNA4 KPNA5	9.82e-08	6	207	4	CID000480797
Drug	Hcda	KPNA1 KPNA3 KPNA4 KPNA5	4.52e-07	8	207	4	CID005312573
Drug	Tat11	KPNA1 KPNA3 KPNA4 KPNA5	8.07e-07	9	207	4	CID000480142
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	ELOVL5 BBS9 PHC3 EHBP1L1 ZBTB40 HSPG2 ICOSLG DUSP2 ADAM22 IL6ST WDTC1	2.12e-06	198	207	11	2251_DN
Drug	AC1NE2UB	NOVA2 KPNA1 KPNA3 KPNA4 KPNA5 NAT10	1.17e-05	56	207	6	CID004635684
Drug	Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; HL60; HT_HG-U133A	ATP7B FSTL3 ALDH1L1 NECTIN2 KCNMB4 PLCB3 NCR2 PCLO ICAM1 CD160	1.37e-05	197	207	10	2954_UP
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A	FSTL3 ALDH1L1 EHBP1L1 PVR PLCB3 TPST2 HSPG2 ICOSLG NTRK2 PCDH1	1.43e-05	198	207	10	5422_UP
Drug	dmDBP	KPNA1 KPNA3 KPNA4	1.45e-05	6	207	3	CID005316801
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ALDH1L1 BBS9 EHBP1L1 PVR HERC3 HSPG2 ICOSLG ADAM22 QSER1 IL6ST	1.49e-05	199	207	10	2289_DN
Drug	NL-2	KPNA1 KPNA3 KPNA4 KPNA5	1.84e-05	18	207	4	CID011846801
Disease	OROFACIAL CLEFT 1	PVR NECTIN2	4.76e-05	2	204	2	C1861537
Disease	3C syndrome	WASHC5 CCDC22	4.76e-05	2	204	2	C0796137
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	EHBP1L1 NECTIN2 PLCB3 LILRA5 NOVA2 PGS1 ASGR1	6.73e-05	144	204	7	EFO_0004611, EFO_0020943
Disease	skin disease (implicated_via_orthology)	C1QTNF9B C1QTNF9	1.42e-04	3	204	2	DOID:37 (implicated_via_orthology)
Disease	Schwartz-Jampel syndrome	HSPG2 IL6ST	1.42e-04	3	204	2	cv:C0036391
Disease	Polydactyly	TCTN3 BBS4 BBS9 HYLS1 TTC21B CKAP2L	1.68e-04	117	204	6	C0152427
Disease	Congenital myotonia	HSPG2 IL6ST	2.83e-04	4	204	2	cv:CN295225
Disease	bipolar disorder (is_marker_for)	RELN PTGS2 NTRK2	2.91e-04	19	204	3	DOID:3312 (is_marker_for)
Disease	Major Depressive Disorder	RELN ATP7B NCAM1 PTGS2 KPNA3 KALRN NTRK2 PCLO	3.06e-04	243	204	8	C1269683
Disease	Prostatic Neoplasms	ATP7B TLR6 PTGS2 ST14 PVR NECTIN2 MGA ASZ1 ICAM1 AOX1 IRAK4 CTNNB1 IL6ST	3.85e-04	616	204	13	C0033578
Disease	Malignant neoplasm of prostate	ATP7B TLR6 PTGS2 ST14 PVR NECTIN2 MGA ASZ1 ICAM1 AOX1 IRAK4 CTNNB1 IL6ST	3.85e-04	616	204	13	C0376358
Disease	Unipolar Depression	RELN ATP7B NCAM1 PTGS2 KPNA3 KALRN NTRK2 PCLO	4.67e-04	259	204	8	C0041696
Disease	Behcet Syndrome	ERAP1 ITGAL ICAM1	5.92e-04	24	204	3	C0004943
Disease	Disorder of eye	TCTN3 BBS4 BBS9 EYS PPT1 TTC21B RP2	7.14e-04	212	204	7	C0015397
Disease	Alzheimer disease, high density lipoprotein cholesterol measurement	PVR NECTIN2 LILRA5	7.53e-04	26	204	3	EFO_0004612, MONDO_0004975
Disease	smooth surface dental caries	ITGAL BBS9 KPNA4 BPIFA3	9.04e-04	62	204	4	EFO_0006339
Disease	prostate carcinoma in situ (is_marker_for)	PTGS2 ST14 CARM1	9.39e-04	28	204	3	DOID:8634 (is_marker_for)
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	NECTIN2 SEC16A PLCB3 NOVA2 PGS1 ASGR1 HELZ2	1.01e-03	225	204	7	EFO_0008317, EFO_0020947
Disease	cholangiocarcinoma (is_marker_for)	NCAM1 PTGS2 MUC5B RASSF8	1.02e-03	64	204	4	DOID:4947 (is_marker_for)
Disease	Ciliopathies	BBS4 BBS9 PKHD1 HYLS1 TTC21B	1.02e-03	110	204	5	C4277690
Disease	Colorectal Carcinoma	ATP7B OBSCN ALDH1L1 PTGS2 PKHD1 NCR1 KALRN ABCB6 ADAMTSL3 PPP2R1B CTNNB1 IL6ST SORL1	1.28e-03	702	204	13	C0009402
Disease	tyrosine-protein kinase receptor TYRO3 measurement	TYRO3 MGA	1.30e-03	8	204	2	EFO_0020829
Disease	morbid obesity (is_implicated_in)	BBS4 NTRK2	1.30e-03	8	204	2	DOID:11981 (is_implicated_in)
Disease	mean reticulocyte volume	AGO2 TMC6 ELOVL5 DFFB ZBTB40 PGS1 RASA2 ZNF510 PPP2R1B RESF1 LPIN2 HELZ2 ELF1 DBR1	1.41e-03	799	204	14	EFO_0010701
Disease	creatinine measurement	SOX5 TRPC1 TMC6 OBSCN ALDH1L1 PTGS2 ST14 NECTIN2 PKHD1 FH KPNA3 TRIM46 TAFA3 TTC27 SLC28A2 SORL1	1.59e-03	995	204	16	EFO_0004518
Disease	Mental deterioration	NECTIN2 SORL1	1.66e-03	9	204	2	C0234985
Disease	Mild cognitive disorder	NECTIN2 SORL1	1.66e-03	9	204	2	C1270972
Disease	malaria (implicated_via_orthology)	FCGR2A ICAM1	1.66e-03	9	204	2	DOID:12365 (implicated_via_orthology)
Disease	idiopathic pulmonary fibrosis (is_implicated_in)	PTGS2 MUC5B	1.66e-03	9	204	2	DOID:0050156 (is_implicated_in)
Disease	Inflammatory Bowel Diseases	ITGAL PTGS2 ICAM1	1.81e-03	35	204	3	C0021390
Disease	otitis media (is_marker_for)	ICAM1 MUC5B	2.06e-03	10	204	2	DOID:10754 (is_marker_for)
Disease	nephritis (implicated_via_orthology)	ITGAL ICAM1	2.06e-03	10	204	2	DOID:10952 (implicated_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	NECTIN2 SEC16A PLCB3 NOVA2 PGS1 KCTD10 HELZ2	2.51e-03	264	204	7	EFO_0008317, EFO_0020944
Disease	granulosa cell tumor (is_marker_for)	PTGS2 ST14	2.51e-03	11	204	2	DOID:2999 (is_marker_for)
Disease	Adrenal Gland Neoplasms	PTGS2 CTNNB1	2.51e-03	11	204	2	C0001624
Disease	Bardet-Biedl syndrome (implicated_via_orthology)	BBS4 BBS9	2.51e-03	11	204	2	DOID:1935 (implicated_via_orthology)
Disease	Adrenal Cancer	PTGS2 CTNNB1	2.51e-03	11	204	2	C0750887
Disease	Kidney Neoplasm	ATP7B PTGS2 FH	2.66e-03	40	204	3	C0022665
Disease	ascending aortic diameter	NCAM1 ABCC9 HMCN1 ATP2B1 HYDIN	2.95e-03	140	204	5	EFO_0021787
Disease	colitis (biomarker_via_orthology)	PTGS2 NTRK2 ICAM1	3.07e-03	42	204	3	DOID:0060180 (biomarker_via_orthology)
Disease	Obesity	BBS4 ALDH1L1 BBS9 PTGS2 NTRK2 ICAM1	3.12e-03	205	204	6	C0028754
Disease	schizophrenia (is_marker_for)	RELN NCAM1 NTRK2	3.50e-03	44	204	3	DOID:5419 (is_marker_for)
Disease	mood disorder	RELN SORL1	3.53e-03	13	204	2	EFO_0004247
Disease	xanthine measurement	ADAM22 EYS	3.53e-03	13	204	2	EFO_0010548
Disease	Malignant neoplasm of kidney	ATP7B PTGS2 FH	3.73e-03	45	204	3	C0740457
Disease	obesity (implicated_via_orthology)	BBS4 SEC16A PLCB3 LPIN2 CTNNB1 WDTC1	3.93e-03	215	204	6	DOID:9970 (implicated_via_orthology)
Disease	urate measurement	DCST1 NECTIN2 PKHD1 ANKRD28 PLCB3 HERC3 MPPED2 ANKRD52 TRIM46 MED30 KRT17 CD160 PPP2R1B NINL	3.94e-03	895	204	14	EFO_0004531
Disease	Thrombus	PTGS2 TYRO3 FCGR2A	3.97e-03	46	204	3	C0087086
Disease	Impaired cognition	NECTIN2 SORL1	4.10e-03	14	204	2	C0338656
Disease	total blood protein measurement	SOX5 MYNN EHBP1L1 SEC16A PKHD1 VAT1 PGS1 RASA2 HYDIN	4.22e-03	449	204	9	EFO_0004536
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	NECTIN2 PLCB3 NOVA2 PGS1 COPB1 ASGR1 HELZ2	4.28e-03	291	204	7	EFO_0008317, EFO_0020946
Disease	mean corpuscular hemoglobin concentration	SOX5 AGO2 ATP7B TMC6 MYNN EHBP1L1 NECTIN2 SEC16A PLCB3 STX7 KPNA1 PGS1 KALRN ELF1 KIF4B DOT1L	4.45e-03	1105	204	16	EFO_0004528
Disease	sexual dimorphism measurement	SOX5 DCST1 EHBP1L1 CRLF3 NECTIN2 SEC16A PLCB3 MGA MPPED2 LILRA5 KPNA3 KRT17 RASA2 ADAMTSL3 CTNNB1 DOT1L	4.49e-03	1106	204	16	EFO_0021796
Disease	acute graft vs. host disease, donor genotype effect measurement	KALRN EYS	4.71e-03	15	204	2	EFO_0004599, EFO_0007892
Disease	Thrombosis	PTGS2 TYRO3 FCGR2A	4.75e-03	49	204	3	C0040053
Disease	Atrial Fibrillation	SOX5 USP3 HSPG2 ABCC9 SORL1	5.20e-03	160	204	5	C0004238
Disease	developmental dysplasia of the hip	REG3G ADAMTSL3	5.35e-03	16	204	2	EFO_1000648
Disease	response to triptolide, cytotoxicity measurement	TECRL ADGRA2	5.35e-03	16	204	2	EFO_0006952, EFO_0007662
Disease	Malaria, susceptibility to	FCGR2A ICAM1	5.35e-03	16	204	2	cv:C1970028
Disease	cutaneous Leishmaniasis	CRLF3 STX7	5.35e-03	16	204	2	EFO_0005046
Disease	–	FCGR2A ICAM1	5.35e-03	16	204	2	611162
Disease	Squamous cell carcinoma of the head and neck	ATP7B PTGS2 TBCK	5.61e-03	52	204	3	C1168401
Disease	alcohol consumption measurement	SOX5 DLG5 RELN NCAM1 TYRO3 DFFB PKHD1 KCNMB4 PLCB3 MGA MPPED2 COL12A1 RASA2 NTRK2 PCLO TSPAN5 SORL1	5.91e-03	1242	204	17	EFO_0007878
Disease	Bardet-Biedl syndrome 1 (disorder)	BBS4 BBS9	6.04e-03	17	204	2	C2936862
Disease	Mouth Neoplasms	ATP7B PTGS2 ICAM1	6.23e-03	54	204	3	C0026640
Disease	Malignant neoplasm of mouth	ATP7B PTGS2 ICAM1	6.23e-03	54	204	3	C0153381
Disease	apolipoprotein B measurement	PNLDC1 PVR NECTIN2 PLCB3 MPPED2 NOVA2 CARM1 PGS1 ATXN1L ASGR1 HYDIN	6.70e-03	663	204	11	EFO_0004615
Disease	Bardet-Biedl syndrome	BBS4 BBS9	6.77e-03	18	204	2	cv:C0752166
Disease	schizophrenia, inflammatory bowel disease	FCGR2A ZSWIM6	6.77e-03	18	204	2	EFO_0003767, MONDO_0005090

Protein segments in the cluster

Peptide	Gene	Start	Entry
TSVSALVGFIQCQLI	TTC21B	356	Q7Z4L5
SNLDCVNEVIGIRQL	PPP2R1A	386	P30153
DCVNEVIGIRQLSQS	PPP2R1B	401	P30154
QACGQLLDEAQVTLS	C2orf42	346	Q9NWW7
LLLVVVCVIGSQNSQ	ASGR1	51	P07306
VCVIGSQNSQLQEEL	ASGR1	56	P07306
LVQGLVEECQAALQN	KCTD10	116	Q9H3F6
GNIQESLELFQTCAV	BBS4	81	Q96RK4
QVLTSNVQTICNGTV	ELF1	506	P32519
EACIVEALGIQTLTN	ANKLE1	551	Q8NAG6
QQFLVNTNCAVVVLL	CXorf65	11	A6NEN9
ACRDVQQTVLQVGQF	DDX4	511	Q9NQI0
QFQDCIIQGLTETGT	BZW1	31	Q7L1Q6
LTNLQLAQSQVCEAG	ADGRA2	1136	Q96PE1
LAIVDIQSGGCINIT	CD160	16	O95971
RNQVQGTCSTTLIAI	ATP7B	351	P35670
GQKCTVAINVLLAQT	CHRNG	271	P07510
ITQTRNASICQAVGI	ADGRA3	816	Q8IWK6
ESLQLQQLIESGACV	ASB13	31	Q8WXK3
QQLIESGACVNQVTV	ASB13	36	Q8WXK3
QVLEGRNEVLCVLTQ	GSDME	146	O60443
NVLQEDSVTLTCQGA	FCGR2A	51	P12318
ITSTLVVQQGRTLNC	ADAM22	621	Q9P0K1
VECVDVLINQGASIL	ANKRD28	596	O15084
QASEVLLQCLQVALG	CFAP46	2041	Q8IYW2
CIRIDGQDISQVTQA	ABCB6	646	Q9NP58
VRDLSQQCQGDTVIS	ACAP3	61	Q96P50
LCISGIVQRVNETQN	ABCC9	316	O60706
QVGLIQAAQQLLCDE	DFFB	96	O76075
QALNIQQVLLEGVLC	DNHD1	691	Q96M86
VGQVVLQVAAATNCK	DOT1L	166	Q8TEK3
VSTNGALCLELLVNN	ANKRD52	281	Q8NB46
NCSQLIQTIEDTGTI	CCDC22	566	O60826
NENDIVTGLTCIAVV	ATP2B1	666	P20020
QCGHLITAVQNVITE	ASZ1	366	Q8WWH4
LQQESGQTVECTVAQ	AGO2	296	Q9UKV8
IAAIRGQDACVQALI	ANKRD42	71	Q8N9B4
VGQLVCAVLADSEVQ	AOX1	671	Q06278
TGDDIQTQVILNCSA	KPNA5	326	O15131
DQVGQVLTCSLETGL	MUC5B	1841	Q9HC84
TTCQEVVIALAQAIG	RASSF8	21	Q8NHQ8
SVTEGQTLDLNCVVA	HSPG2	2061	P98160
SQVAEGQTLDLNCLV	HSPG2	2446	P98160
VVEGQTLDLNCVVAR	HSPG2	2641	P98160
VQDGVLRIQNLDQSC	HSPG2	3446	P98160
ELITENGTVCQQLVV	RASA2	161	Q15283
CDLQILQQSILQAGL	QSER1	731	Q2KHR3
VACTQQLSNGTLIRA	ADAMTS19	1001	Q8TE59
LNQCLESLVQKVQSG	INTS6L	216	Q5JSJ4
LNQCLESLVQKVQSG	INTS6	216	Q9UL03
TVCFQNLREVGNAIL	CYFIP1	991	Q7L576
ELQRVGCVELLNTVQ	MPPED2	226	Q15777
GIARLACANITVNIV	OR52D1	186	Q9H346
QNAQLVNSLEGCQLI	FAM189A1	116	O60320
VQLLGSDDINVVTCA	CTNNB1	406	P35222
IVTGDDIQTQVILNC	KPNA6	321	O60684
IVTGTDEQTQVVLNC	KPNA3	311	O00505
NSVTIRCQGTLEAQE	LILRA5	61	A6NI73
LEAQQEALGLVCVQA	MAGEA1	16	P43355
FVGCVQNTTTEDQLL	EYS	111	Q5T1H1
LAVLQGVCAEVQLVQ	IGHV5-10-1	11	A0A0J9YXX1
VGLCLSQRISAQQQT	NCR1	11	O76036
QVLQSVAGQTLTVRC	NCR2	26	O95944
TDQGILVTNQDACAL	MGA	36	Q8IWI9
QLLQFVLTIIQTSCG	ELOVL5	206	Q9NYP7
NTINGVVQILSSAAC	HERC3	421	Q15034
GSVNINTIQQLDVFC	NCR3LG1	341	Q68D85
LQVGDVCISISLQSL	ATXN1L	571	P0C7T5
ITNIQLDCGGIQISF	BPIFA3	96	Q9BQP9
QSFIITLGCNSVLIQ	CARM1	96	Q86X55
LQGLQACGITAVLNV	DUSP2	191	Q05923
LQLQIQDTIEGILCD	FSIP2	2086	Q5CZC0
NGSQLRCVQQTIETI	ERAP1	901	Q9NZ08
RCVQQTIETIEENIG	ERAP1	906	Q9NZ08
VQSIISQQSGEAEIC	PCLO	4571	Q9Y6V0
QLEGICLQVIGTVLQ	IPO7	631	O95373
CLQVIGTVLQQHVLE	IPO7	636	O95373
SLQGTATVLVNVLDC	PCDH1	591	Q08174
SEVCSLGQQERVQLQ	PGS1	441	Q32NB8
TCIDQVQTFGDILQL	COPB1	211	P53618
LQRDQAVCISTNGAV	CRLF3	346	Q8IUI8
QQCLQAVLIFSGLEI	CUL7	1246	Q14999
ICNSVALEIQQLLVG	FAM205A	106	Q6ZU69
IQIGQVCASDVATQT	INTS2	1126	Q9H0H0
CVSQGEVVQVLAVNQ	KALRN	2341	O60229
TEQQARLIIGQQCDT	DLG5	1406	Q8TDM6
QIRAFCTGQELQLVQ	EHBP1L1	1136	Q8N3D4
SITGNIELNQQTCLL	MYNN	131	Q9NPC7
ITQETINGRLVLCQV	KRT23	401	Q9C075
GFQIINTASIQSLIC	PTGS2	541	P35354
SCSQLIEQTLDAIGQ	LRRC29	161	Q8WV35
IEQTLDAIGQACRQL	LRRC29	166	Q8WV35
ECVLQILQSQGDSLG	MON2	886	Q7Z3U7
EQFIAQLENGCVSQI	OVOS2	266	Q6IE36
QLENGCVSQIVNTKV	OVOS2	271	Q6IE36
SNQVINVGLILIAIC	OVOS2	1226	Q6IE36
ELRCVQAQEGQLTTQ	HOOK3	426	Q86VS8
QTCGNVAQTVIRSLN	MFSD11	26	O43934
RVCLVQGTAEALNAV	NOVA2	81	Q9UNW9
LEGVRNVASVCLQIG	RPLP0	216	P05388
LLQEQQTITFVGCII	OR5AN1	86	Q8NGI8
LLDNQVINSVCVQPE	PHC3	736	Q8NDX5
ASLCRIGQETVQDIV	MED30	31	Q96HR3
TQNALPEVLAVIQVC	NAT10	566	Q9H0A0
IGEQALDICIVSFNQ	BBS9	241	Q3SYG4
SLQVLNLSGNCFQEV	LRRC58	121	Q96CX6
QLCGVFLQNETNETI	MAS1L	46	P35410
NENTIIQFEINVGCS	RELN	2016	P78509
VVVNNFISLTCEVSG	HMCN1	2976	Q96RW7
VSVLLGENVELVCNA	HMCN1	3256	Q96RW7
IVNVQTTLACEATGI	HMCN1	3816	Q96RW7
LAVLQGVCAEVQLVQ	IGHV5-51	11	A0A0C4DH38
CIENVLLQQNLTVGS	ICOSLG	216	O75144
TCDIGQAQSRAQLLV	OBSCN	2986	Q5VST9
DETVVLGQSVTLACQ	OBSCN	7471	Q5VST9
AVLCNPSNTEEIIQV	LPCAT2	421	Q7L5N7
CVTNLQEVARIVGNS	CTSA	256	P10619
LNVNSQVTTVCQALA	PPT1	86	P50897
RQEGCQDIATQLISN	ALPP	201	P05187
NVGCQLVALNFQTLD	PLCB3	666	Q01970
LNVITETQCTLGLTA	PHF10	126	Q8WUB8
SIEVQLGTTLIVDCN	IL1RL2	236	Q9HB29
EDIQTLRVVTVCNGN	OTOP1	456	Q7RTM1
LLLAIEICTGNINSQ	C1QTNF9	6	P0C862
IQCGQCLVETIQLSN	HYDIN	1711	Q4G0P3
QVLAIELLAACQGIE	HAL	551	P42357
LTCNILTFGQLEQNV	IL6ST	101	P40189
QGISQDQLICSLQRE	HYLS1	161	Q96M11
CVQLSQIQGLIGSVE	KRT17	336	Q04695
VDIQNEIISQVCSGV	COL12A1	306	Q99715
SVIQVFQQLGCAVID	DCAKD	16	Q8WVC6
NNVIASLGCTVELQI	DCST1	141	Q5T197
QQGQEATCSLVLQTD	FSTL3	41	O95633
VFQGLSQEALSACIQ	COG3	576	Q96JB2
TENCVVGIQANTERI	FH	431	P07954
VSQLLTCEDIQGSAV	FRRS1	101	Q6ZNA5
GIEVQQLFCSQSAAI	GARRE1	251	O15063
LLLAIEICTGNINSQ	C1QTNF9B	6	B2RNN3
VCNQLEALVGLAANV	MAN2B1	411	O00754
VLVALDTVSCLEQGN	KIF4A	181	O95239
VLVALDTVSCLEQGN	KIF4B	181	Q2VIQ3
EANCTVLSVQQIGEV	KCNMB4	51	Q86W47
QTTEFCAQLGIIDIN	DBR1	366	Q9UK59
QRLTCAVILGNQSQE	ICAM1	286	P05362
TTNCTVGDLVDLLIQ	IRAK4	76	Q9NWZ3
QSQLVVVGDAVALCS	HELZ2	906	Q9BYK8
CLQAQELQGHVSIIL	H6PD	16	O95479
IVIQLSTNDGECVTV	DYNAP	146	Q8N1N2
SDQLGCEVLNLLTAQ	SLFN13	566	Q68D06
ILETQAQVCQALAQV	CPOX	156	P36551
NQAQCLINVSGDAVV	C2CD5	956	Q86YS7
QIAAVCLAVLQALSV	PAK4	416	O96013
SCLILLCQVQGEETQ	REG3G	16	Q6UW15
CGSASIVSLLLQQNI	POTEA	241	Q6S8J7
QEALQGLQVALCSQA	FES	361	P07332
CQDQLLRVAVDTGTQ	NRIP2	166	Q9BQI9
QLELQLGQETVVCSA	NRIP2	216	Q9BQI9
AQLIGTCSQNVAAIQ	HSPBP1	166	Q9NZL4
TCSQNVAAIQEQVLG	HSPBP1	171	Q9NZL4
INTTLICNVTNALGA	PVR	306	P15151
TATVLVQQGTCEVIA	TAFA3	36	Q7Z5A8
VIDGQERLCLAQISN	SKOR1	91	P84550
VLGSIAIITAQNLSC	SLC35G3	316	Q8N808
VIQRLCLNGSTGQEV	SORL1	811	Q92673
LQSQLSVPEIEACVQ	SNX11	126	Q9Y5W9
ILGNQDTVQTQICEL	TRIM46	281	Q7Z4K8
VGCESANTQVLQVSE	TMEM132A	441	Q24JP5
TQCSVEIQRTLNQLG	STX7	26	O15400
VIKEGSVCSLQNQLA	RESF1	791	Q9HCM1
LSGINVLQNCEVALS	SEL1L2	226	Q5TEA6
GDDIQTQVILNCSAL	KPNA1	326	P52294
SGCVTLELIINQLQG	FASTKD3	231	Q14CZ7
TRQSVQQFTVCQIGL	PNLDC1	46	Q8NA58
SDQLGCEVLNLLTAQ	SLFN11	566	Q7Z7L1
VNRILSAVQNTLCTG	SMCR5	31	Q8TEV8
QLVSNISACQVIAEA	CCT7	21	Q99832
NSVILLGNLNCDVET	PKHD1	1326	P08F94
VTVLVNGLTSECQGN	PKHD1	1461	P08F94
IGVLLSTQNNRCVSA	RNF169	326	Q8NCN4
VCVQDLISPINVSLN	ITGAL	716	P20701
LSEQELAVVCQSVGL	NINL	216	Q9Y2I6
LQVLVEEAFGCQLQN	EARS2	376	Q5JPH6
GTSTVEQLLENVCLL	RRP12	936	Q5JTH9
ELVDIQGLTFQVICS	SLC28A2	446	O43868
IAQGIITLDNCSNDL	TET1	1021	Q8NFU7
DGSVICQVSLAQVTD	ALDH1L1	446	O75891
INNTLTECLNLIEGG	CKAP2L	521	Q8IYA6
LAVTSQVINCRNQAV	NCAPD3	321	P42695
VNATANLGQSVTLVC	NCAM1	221	P13591
QLSNNEVIECITQGR	NTRK2	756	Q16620
NINCVDVLGRNAVTI	TRPC1	76	P48995
QAIVSVLLNCTHQDV	UCHL5	91	Q9Y5K5
AVQLGQQVLECRAVL	TPST2	21	O60704
NLVRVLQGDESIVNC	WDTC1	571	Q8N5D0
LQEGIAQSKCLINVS	LINC02912	56	Q8N9X5
INLSTLEGCGNNLVV	ZPLD1	96	Q8TCW7
AENNLCGQAILRIVS	WASHC5	6	Q12768
LLQVRQGSQATLVCQ	TMIGD2	31	Q96BF3
IVLLCRQNGTVVGTD	SEC16A	1541	O15027
QNCLVFQGTVESISV	SMC1B	131	Q8NDV3
TVLQIDCGLQLANDS	SPAG1	546	Q07617
GEIRVINQTTCENLL	ST14	766	Q9Y5Y6
GAVEVCQLIVNEIFN	RP2	306	O75695
IGNFATCIVARNQLT	SRRD	146	Q9UH36
ACAVLVTAQNLLVAA	TMEM88	26	Q6PEY1
SESEQCLSQIQELIG	ARHGAP9	661	Q9BRR9
STVLCIAFEVLQGLQ	TBCK	91	Q8TEA7
QEQGSSQIRLCLQVL	RALGAPB	131	Q86X10
IQVNISVNTLGCLQL	TLR6	211	Q9Y2C9
CNNSAVIVQVITQVG	ZNF717	246	Q9BY31
TAIFGGILQNEVNCL	USP3	311	Q9Y6I4
LQIFGICLAQNLVSD	TSPAN5	246	P62079
VTALQLLQANRAVCG	VAT1	311	Q99536
IALLESGCVDNVLQV	ZSWIM6	211	Q9HCJ5
DINSVSSICAIQVGI	ZNF215	311	Q9UL58
EAITDCVTLNTVGQL	ZNF510	6	Q9Y2H8
VAVVNSLGLNNCRTE	SOX5	481	P35711
QLIQEQSQCTAQEGL	TMC6	36	Q7Z403
GNRQITVSAINFLIC	TECRL	246	Q5HYJ1
EVTAVEGAIVQINCT	TRAV1-1	26	A0A0B4J248
LLAGNTCQNVVSQVT	TCTN3	311	Q6NUS6
AEEIAIILGICTNFQ	TTC27	341	Q6P3X3
VGNACLLSVFQVITI	VN1R3	96	Q9BXE9
GRALLQSCTVQVTQA	TYRO3	251	Q06418
NLLTSLVNCSVQGQV	ZBTB40	111	Q9NUA8
LVNCSVQGQVVRDVS	ZBTB40	116	Q9NUA8
QNLTAQEGEFITINC	TRAV41	31	A0A0B4J266
TQIQATFCISELQVQ	VPS13D	1616	Q5THJ4
EAIAVCLHIQTQQTV	ADAMTSL3	666	P82987
IVTGTDEQTQVVLNC	KPNA4	311	O00629
TLSGCIDVIVVQQQD	LPIN2	26	Q92539
VNNLVEAFGNACTII	MYO3A	466	Q8NEV4
VVTIQEGKALNLTCN	MYOM1	1581	P52179
ATAVAATGILICRQQ	NECTIN2	371	Q92692